Trade Gilead ^GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lowered by Ontario Teachers Pension Plan Board

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by First Horizon Advisors Inc.

Advisors Asset Management Inc. Sells 18,896 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of “Moderate Buy” from Analysts

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts

B. Metzler seel. Sohn & Co. Holding AG Takes $9.52 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Meeder Asset Management Inc. Purchases 42,444 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Belmont Capital LLC

Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Wolfe Research

Royal Bank of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock

5,715 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Aljian Capital Management LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by TrinityPoint Wealth LLC

Transforming the landscape of liver cancer detection and care

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study - November 18, 2024 - Zacks.com

Eyenovia Stock Tumbles on Termination of Phase III Myopia Study - November 18, 2024 - Zacks.com

Swiss National Bank Purchases 5,900 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Thrivent Financial for Lutherans Acquires 28,090 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead's Livdelzi Shows Sustained Efficacy, Long-Term Safety In PBC Management

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Kentucky Retirement Systems

CIBC Asset Management Inc Purchases 22,624 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Impax Asset Management Group plc Sells 7,979 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Harbour Investments Inc. Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead’s Irish business sees profit slump on falling sales of Covid drug

Gilead on Pace for Largest Percent Decrease Since February — Data Talk | Morningstar

Altrius Capital Management Inc Sells 1,805 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Upgraded by Citigroup to “Strong-Buy” Rating

Livdelzi shows promise in PBC treatment study By Investing.com

Empowered Funds LLC Reduces Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Coverage Initiated at Wolfe Research

Dearborn Partners LLC Has $26.76 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Intellectus Partners LLC Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Citigroup Upgrades Gilead Sciences (NASDAQ:GILD) to Strong-Buy

ING Groep NV Buys 109,788 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Thursday's biggest stock analyst calls like Nvidia

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Bell Bank

Prime Capital Investment Advisors LLC Sells 14,908 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Prices $3.5 Bln Of Senior Unsecured Notes

Gilead Prices $3.5 Billion of Senior Unsecured Notes | Morningstar

Company Website: https://www.gilead.com/ FOSTER CITY, Cali

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - November 14, 2024 - Zacks.com

Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet - November 14, 2024 - Zacks.com

Citi sets $125 target on Gilead with Buy rating By Investing.com

5 Biggest Biotechnology ETFs in 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Boosted by Sumitomo Mitsui Trust Group Inc.

Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight

Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from TD Cowen

TD Cowen Sticks to Its Buy Rating for Olema Pharmaceuticals (OLMA)

Carrera Capital Advisors Has $2.14 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Victory Capital Management Inc. Sells 468,814 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Elanco boosts board with biopharma expert Dr. Stacey Ma By Investing.com

Elanco Strengthens Board of Directors with Addition of Stacey Ma | Morningstar

Truist Financial Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Atria Investments Inc Sells 3,854 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Lowered to “Hold” Rating by Maxim Group

Elanco Animal Health Appoints Stacey Ma to its Board By Investing.com

Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High Following Analyst Upgrade

Tyler Stone Wealth Management Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Colonial River Investments LLC

Gilead Sciences stock hits 52-week high at $98.34 By Investing.com

Moving toward response-adapted trials in oncology

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Crossmark Global Holdings Inc.

AIA Group Ltd Sells 18,541 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) & Taysha Gene Therapies (NASDAQ:TSHA) Head to Head Analysis

Assetmark Inc. Acquires 109,118 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

CWA Asset Management Group LLC Buys New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

Principal Financial Group Inc. Buys 59,181 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

FY2024 EPS Estimate for Gilead Sciences Increased by Analyst

Oppenheimer Increases Gilead Sciences (NASDAQ:GILD) Price Target to $105.00

Oppenheimer Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Gilead Sciences, Inc. Announces Quarterly Dividend of $0.77 (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $97.00 at Truist Financial

Gilead Sciences (NASDAQ:GILD) Rating Lowered to "Hold" at Maxim Group

Foster & Motley Inc. Sells 138 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Confluence Investment Management LLC Sells 11,734 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

M&G Plc Has $14.50 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Q1 EPS Estimates for Gilead Sciences Raised by Analyst

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Royal Bank of Canada Increases Gilead Sciences (NASDAQ:GILD) Price Target to $81.00

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says

Gilead Sciences Stock Near 52-Week High: Key Growth Drivers

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Barclays Analyst Says

Deseret Mutual Benefit Administrators Sells 2,474 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

General American Investors Co. Inc. Buys 25,000 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (GILD) Shares Surge on Strong Q3 Earnings and Raised Forecast

Piper Sandler Increases Gilead Sciences (NASDAQ:GILD) Price Target to $105.00

Gilead Sciences (NASDAQ:GILD) Given “Hold” Rating at Needham & Company LLC

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results | Morningstar

Gilead Sciences (NASDAQ:GILD) Given "Hold" Rating at Needham & Company LLC

GILEAD SCIENCES APPOINTS PAUL PETRELLI TO VICE PRESIDENT AND GENERAL MANAGER IN CANADA

Zacks Research Expects Stronger Earnings for Gilead Sciences

Avidian Wealth Enterprises LLC Purchases 310 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Catalyst Capital Advisors LLC Sells 252 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Q3 2024 Gilead Sciences Inc Earnings Call Transcript

7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle

Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook - November 7, 2024 - Zacks.com

Gilead Sciences Post Higher 3Q Revenue, Raises Fiscal Year Guidance | Morningstar

Gilead Sciences Inc. Q3 Profit Decreases, But Beats Estimates

Zacks Research Boosts Earnings Estimates for Gilead Sciences